Results 21 to 30 of about 3,701,075 (393)

Seven classes of antiviral agents

open access: yesCellular and Molecular Life Sciences, 2022
The viral epidemics and pandemics have stimulated the development of known and the discovery of novel antiviral agents. About a hundred mono- and combination antiviral drugs have been already approved, whereas thousands are in development.
A. Ianevski   +7 more
semanticscholar   +1 more source

Phytochemicals from Plant Foods as Potential Source of Antiviral Agents: An Overview

open access: yesPharmaceuticals, 2021
To date, the leading causes of mortality and morbidity worldwide include viral infections, such as Ebola, influenza virus, acquired immunodeficiency syndrome (AIDS), severe acute respiratory syndrome (SARS) and recently COVID-19 disease, caused by the ...
T. Behl   +15 more
semanticscholar   +1 more source

Incidence of acute kidney injury (AKI) and outcomes in COVID-19 patients with and without antiviral medications: A retrospective study.

open access: yesPLoS ONE, 2023
BackgroundAcute kidney injury is a complication of COVID-19 and is associated with severity. Despite no specific antiviral treatment strategy, lopinavir/ritonavir and remdesivir have been used.
Seyed Majid Mousavi Movahed   +8 more
doaj   +1 more source

Antioxidant Capacity and Antimicrobial Activity of Commercial Samples of Guava Leaves (\u3cem\u3ePsidium guajava\u3c/em\u3e) [PDF]

open access: yes, 2020
Psidium guajava is a small tree native to South and Central America. Guava leaves have traditionally been used for treating different illnesses. These benefits can be attributed to phenolics and flavonoids produced by guava.
Alsaidi, Sahar   +11 more
core   +2 more sources

Metal Complexes as Antiviral Agents for SARS‐CoV‐2

open access: yesChemBioChem, 2021
The severe acute respiratory syndrome – coronavirus 2 (SARS‐CoV‐2), the infectious agent responsible for COVID‐19 – has caused more than 2.5 million deaths worldwide and triggered a global pandemic. Even with successful vaccines being delivered, there is
J. Karges, Seth M. Cohen
semanticscholar   +1 more source

Broad-spectrum antiviral agents

open access: yesFrontiers in Microbiology, 2015
Development of highly effective, broad-spectrum antiviral agents is the major objective shared by the fields of virology and pharmaceutics. Antiviral drug development has focused on targeting viral entry and replication, as well as modulating cellular ...
Jun-Da eZhu   +3 more
doaj   +1 more source

Antiviral Agents: Discovery to Resistance

open access: yesViruses, 2020
In the midst of the SARS-CoV-2/Covid-19 outbreak the need for research into, and development of, antiviral agents is brought into sharp focus worldwide for scientists, governments and the public alike [...]
Catherine S. Adamson
doaj   +1 more source

Variability in antifungal and antiviral use in hospitalized children [PDF]

open access: yes, 2017
We analyzed antifungal and antiviral prescribing among high-risk children across freestanding children’s hospitals. Antifungal and antiviral days of therapy varied across hospitals.
Gerber, Jeffrey S   +6 more
core   +2 more sources

Essential Oils as Antiviral Agents, Potential of Essential Oils to Treat SARS-CoV-2 Infection: An In-Silico Investigation

open access: yesInternational Journal of Molecular Sciences, 2020
Essential oils have shown promise as antiviral agents against several pathogenic viruses. In this work we hypothesized that essential oil components may interact with key protein targets of the 2019 severe acute respiratory syndrome coronavirus 2 (SARS ...
J. D. da Silva   +3 more
semanticscholar   +1 more source

Inhibition of SARS Coronavirus Infection In Vitro with Clinically Approved Antiviral Drugs

open access: yesEmerging Infectious Diseases, 2004
Severe acute respiratory syndrome (SARS) is an infectious disease caused by a newly identified human coronavirus (SARS-CoV). Currently, no effective drug exists to treat SARS-CoV infection.
Emily L.C. Tan   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy